CoChat

Unravelling the metabolic impact of SBS-associated microbial dysbiosis: Insights from the piglet short bowel syndrome model

Open access
Pereira-Fantini, Prue M., Byars, Sean G., Pitt, James, Lapthorne, Susan, Fouhy, Fiona, Cotter, Paul D., Bines, Julie E. · 2017 · Scientific Reports

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Abstract

Liver disease is a major source of morbidity and mortality in children with short bowel syndrome (SBS). SBS-associated microbial dysbiosis has recently been implicated in the development of SBS-associated liver disease (SBS-ALD), however the pathological implications of this association have not been explored. In this study high-throughput sequencing of colonic content from the well-validated piglet SBS-ALD model was examined to determine alterations in microbial communities, and concurrent metabolic alterations identified in urine samples via targeted mass spectrometry approaches (GC-MS, LC-MS, FIA-MS) further uncovered impacts of microbial disturbance on metabolic outcomes in SBS-ALD. Multi-variate analyses were performed to elucidate contributing SBS-ALD microbe and metabolite panels and to identify microbe-metabolite interactions. A unique SBS-ALD microbe panel was clearest at the genus level, with discriminating bacteria predominantly from the Firmicutes and Bacteroidetes phyla. The SBS-ALD metabolome included important alterations in the microbial metabolism of amino acids and the mitochondrial metabolism of branched chain amino acids. Correlation analysis defined microbe-metabolite clustering patterns unique to SBS-ALD and identified a metabolite panel that correlates with dysbiosis of the gut microbiome in SBS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep43326

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The clinical and pathological features of the piglet SBS-ALD model. (A) At six weeks post-surgery animals with short bowel syndrome-associated liver disease (SBS-ALD) exhibited decreased weight gain and increased stool consistency and stool fat scores indicative of persistent diarrhoea and steatorrhoea, when compared with either non-operation (NOC) or sham-operation (SHAM) control animals. Histological evidence of liver disease development in SBS-ALD animals included (B) increased Sirius red staining identifying increased fibrosis and (C) increased Oil Red O staining identifying hepatic fat droplet accumulation. Values are expressed as mean ± standard error of mean; N = 5–6/group. *P < 0.05, **P < 0.01, ***P < 0.001.
Figure 1 The clinical and pathological features of the piglet SBS-ALD model. (A) At six weeks post-surgery animals with short bowel syndrome-associated liver disease (SBS-ALD) exhibited decreased weight gain and increased stool consistency and stool fat scores indicative of persistent diarrhoea and steatorrhoea, when compared with either non-operation (NOC) or sham-operation (SHAM) control animals. Histological evidence of liver disease development in SBS-ALD animals included (B) increased Sirius red staining identifying increased fibrosis and (C) increased Oil Red O staining identifying hepatic fat droplet accumulation. Values are expressed as mean ± standard error of mean; N = 5–6/group. *P < 0.05, **P < 0.01, ***P < 0.001.CC BY · PubMed Central
Figure 2 Multi-variate analysis was performed on high-throughput sequencing results obtained at the phylum (A), family (B), and genus (C) level using colonic content from non-operation controls (NOC), sham-operation controls (sham) or short bowel syndrome (SBS-ALD) animals.
Figure 2 Multi-variate analysis was performed on high-throughput sequencing results obtained at the phylum (A), family (B), and genus (C) level using colonic content from non-operation controls (NOC), sham-operation controls (sham) or short bowel syndrome (SBS-ALD) animals.CC BY · PubMed Central
Figure 3 Multivariate analysis of metabolites identified in urine from non-operation control (NOC), sham-operation control (SHAM) or short bowel syndrome (SBS-ALD) via GC-MS (A), LC-MS (B) or FIA-MS (C).
Figure 3 Multivariate analysis of metabolites identified in urine from non-operation control (NOC), sham-operation control (SHAM) or short bowel syndrome (SBS-ALD) via GC-MS (A), LC-MS (B) or FIA-MS (C).CC BY · PubMed Central
Figure 4 Pathway schematic detailing urine metabolite changes in SBS-ALD animals occurring as a direct or down-stream result of microbial modification. Metabolite names in black were detected in urine samples via FIA-MS. Metabolite names shown in bold represent differentially expressed metabolites and their associated abundance plot (25th to 75th percentile, relative to creatinine) in NOC (blue), sham (red) and SBS-ALD (green) animals, pre-multiple testing correction. *P < 0.05 NOC vs. SBS-ALD, **P < 0.01 NOC vs. SBS-ALD, ***P < 0.001 NOC vs. SBS-ALD, ^P < 0.05 sham vs. SBS-ALD, ^^P < 0.01 vs. SBS-ALD, ^^^P < 0.001 vs. SBS-ALD; black symbols representative uncorrected P value testing, red symbols represent significant metabolites following Bonferroni testing. N = 5–6/group.
Figure 4 Pathway schematic detailing urine metabolite changes in SBS-ALD animals occurring as a direct or down-stream result of microbial modification. Metabolite names in black were detected in urine samples via FIA-MS. Metabolite names shown in bold represent differentially expressed metabolites and their associated abundance plot (25th to 75th percentile, relative to creatinine) in NOC (blue), sham (red) and SBS-ALD (green) animals, pre-multiple testing correction. *P < 0.05 NOC vs. SBS-ALD, **P < 0.01 NOC vs. SBS-ALD, ***P < 0.001 NOC vs. SBS-ALD, ^P < 0.05 sham vs. SBS-ALD, ^^P < 0.01 vs. SBS-ALD, ^^^P < 0.001 vs. SBS-ALD; black symbols representative uncorrected P value testing, red symbols represent significant metabolites following Bonferroni testing. N = 5–6/group.CC BY · PubMed Central
Figure 5 Pathway schematic detailing the mitochondrial metabolism of branched chain amino acids and the associated SBS-ALD associated urine metabolite changes. Metabolite names in black were detected in urine samples via FIA-MS. Metabolite names shown in bold represent differentially expressed metabolites and their associated abundance plot (25th to 75th percentile, relative to creatinine) in NOC (blue), sham (red) and SBS-ALD (green) animals, pre-multiple testing correction. *P < 0.05 NOC vs. SBS-ALD, **P < 0.01 NOC vs. SBS-ALD, ***P < 0.001 NOC vs. SBS-ALD, ^P < 0.05 sham vs. SBS-ALD, ^^P < 0.01 vs. SBS-ALD, ^^^P < 0.001 vs. SBS-ALD; black symbols representative uncorrected P value testing, red symbols represent significant metabolites following Bonferroni testing. N = 5–6/group.
Figure 5 Pathway schematic detailing the mitochondrial metabolism of branched chain amino acids and the associated SBS-ALD associated urine metabolite changes. Metabolite names in black were detected in urine samples via FIA-MS. Metabolite names shown in bold represent differentially expressed metabolites and their associated abundance plot (25th to 75th percentile, relative to creatinine) in NOC (blue), sham (red) and SBS-ALD (green) animals, pre-multiple testing correction. *P < 0.05 NOC vs. SBS-ALD, **P < 0.01 NOC vs. SBS-ALD, ***P < 0.001 NOC vs. SBS-ALD, ^P < 0.05 sham vs. SBS-ALD, ^^P < 0.01 vs. SBS-ALD, ^^^P < 0.001 vs. SBS-ALD; black symbols representative uncorrected P value testing, red symbols represent significant metabolites following Bonferroni testing. N = 5–6/group.CC BY · PubMed Central
Figure 6 Correlation analysis of bacteria at the genus level against MSMS-derived metabolite analysis. Red squares represent positive correlations and blue squares represent negative correlations (P < 0.05). Non-significant results are shown in grey. Surrounding coloured squares act as an overview summary of the significant P values for the correlation analysis, VIP values > 1 and differential microbe/metabolite expression (uncorrected P value; P < 0.05).
Figure 6 Correlation analysis of bacteria at the genus level against MSMS-derived metabolite analysis. Red squares represent positive correlations and blue squares represent negative correlations (P < 0.05). Non-significant results are shown in grey. Surrounding coloured squares act as an overview summary of the significant P values for the correlation analysis, VIP values > 1 and differential microbe/metabolite expression (uncorrected P value; P < 0.05).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Cited by

Metadata

Authors
Pereira-Fantini, P. M., Byars, S. G., Pitt, J., Lapthorne, S., Fouhy, F., Cotter, P. D., & Bines, J. E.
Affiliations
  • The University of Melbourne (AU)
  • Murdoch Children's Research Institute (AU)
  • Teagasc - The Irish Agriculture and Food Development Authority (IE)
  • Royal Children's Hospital (AU)
Venue
Scientific Reports
Published
2017-02-23
Volume
7
Issue
1
Pages
43326-43326
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2589697601
Cited by
22
References
47
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 1
FWCI
1.12
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • T-Stór (Teagasc) (acceptedVersion, cc-by-nc-sa)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • Arrow@dit (Dublin Institute of Technology) (submittedVersion, cc-by-nc-sa)
  • HAL (submittedVersion)
Funders
  • Science Foundation Ireland (SFI/12/RC/, 12/RC/2273, 12/RC/, SFI/12/RC/2273.)
  • State Government of Victoria
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
  • Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Nutrition and Physiology
Keywords
short bowel syndrome, gut dysbiosis, piglet model, microbial metabolites, urinary metabolome, amino acid metabolism, branched-chain amino acids, mitochondrial metabolism, Firmicutes, Bacteroidetes, colonic microbiota
MeSH terms
Gastrointestinal Microbiome, Animals, Animals, Newborn, Colon, Disease Models, Animal, Liver Diseases, Short Bowel Syndrome, Mass Spectrometry, Swine, Urine, Urinalysis, Metabolome, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.